The biology of replicative senescence

European Journal of Cancer Part A

Volumn 33, Issue 5, 1997, Pages 703-709

  Campisi, J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

ageing; cancer; replicative senescence; somatic cells; tumour suppression

Indexed keywords

CANCER INHIBITION; CARCINOGENESIS; CELL AGING; CELL DIVISION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TELOMERE;

EID: 0030964277     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00058-5     Document Type: Article

References (79)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37, 614-636.
2. Stanulis-Praeger B. Cellular senescence revisited: a review. Mech Ageing Dev 1987, 38, 1-48.
3. Campisi J, Dimri GP, Hara E. Control of replicative senescence. In Schneider E, Rowe J, eds. Handbook of the Biology of Aging. New York, Academic Press, 1996, 121-149.
4. Campisi J. Replicative senescence: an old lives tale? Cell 1996, 84, 497-500.
5. Jazwinski SM. The genetics of aging in the yeast Saccharomyces cerevisiae. Genetica 1993, 91, 35-51.
6. Sager R. Senescence as a mode of tumor suppression. Environ Health Persp 1991, 93, 59-62.
7. McCormick JJ, Maher VM. Towards an understanding of the malignant transformation of diploid human fibroblasts. Mutat Res 1988, 199, 273-291.
8. Shay JW, Wright WE. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1991, 1071, 1-7.
9. Pereira-Smith OM, Smith JR. Evidence for the recessive nature of cellular immortality. Science 1983, 221, 964-967.
10. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 1988, 85, 6042-6046.
11. King Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM. Genetic analysis of indefinite division in human cells: evidence for a senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 1991, 88, 5635-5639.
12. Hensler P, Annab LA, Barrett JC, Pereira-Smith OM. A gene involved in control of human cellular senescence on human chromosome 1q. Mol Cell Biol 1994, 14, 2292-2297.
13. Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M. Chromosome 7 suppresses indefinite division of non-tumorigenic immortalized human fibroblast cell lines KMST-6 and SUSM-1. Mol Cell Biol 1993, 13, 6036-6043.
14. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science 1990, 249, 1129-1133.
15. Rittling SR, Brooks KM, Cristofalo VJ, Baserga R. Expression of cell cycle dependent genes in young and senescent WI38 fibroblasts. Proc Natl Acad Sci USA 1986, 83, 3316-3320.
16. Seshadri T, Campisi J. c-fos repression and an altered genetic program in senescent human fibroblasts. Science 1990, 247, 205-209.
17. Hara E, Yamaguchi T, Nojima H, et al. Id related genes encoding helix loop helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 1994, 269, 2139-2145.
18. Dimri GP, Hara E, Campisi J. Regulation of two E2F related genes in presenescent and senescent human fibroblasts. J Biol Chem 1994, 269, 16180-16186.
19. Good LF, Dimri GP, Campisi J, Chen KY. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence. J Cell Physiol 1996, 168, 580-588.
20. Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 1990, 249, 666-669.
21. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211, 90-98.
22. Hara E, Smith R, Parry D, Tahara H, Peters G. Regulation of p16 (CdkN2) expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996, 16, 859-867.
23. Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-cdk and cyclin D-cdk complexes. Proc Natl Acad Sci USA 1993, 90, 11034-11038.
24. Dimri GP, Nakanishi M, Desprez PY, Smith JR, Campisi J. Inhibition of E2F activity by the p21 inhibitor of cyclin-dependent protein kinases in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol 1996, 16, 2987-2997.
25. Hara E, Uzman JA, Dimri GP, Nehlin JO, Testori A, Campisi J. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts. Dev Genetics 1996, 18, 161-172.
26. Wang E. Senescent human fibroblasts resist programmed cell death and failure to suppress bcl2 is involved. Cancer Res 1995, 55, 2284-2292.
27. Linskens M, Harley CB, West MD, Campisi J, Hayflick L. Replicative senescence and cell death. Science 1995, 267, 17.
28. Maier JAM, Voulalas P, Roeder D, Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1x anti-sense oligomer. Science 1990, 249, 1570-1574.
29. Maier JAM, Statuto M, Ragnoti G. Senescence stimulates U037-endothelial cell interactions. Exp Cell Res 1993, 208, 270-274.
30. Swisshelm K, Ryan K, Lee X, Tsou H, Peacocke M, Sager R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Diff 1994, 5, 133-141.
31. West MD, Pereira-Smith OM, Smith JR. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res 1989, 184, 138-137.
32. Millis AJ, Hoyle M, McCue HM, Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res 1992, 201, 373-379.
33. Wick M, Burger C, Brusselbach S, Lucibello FC, Muller R. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation and senescence. J Biol Chem 1994, 269, 18953-18960.
34. Finch CE. Longevity, Senescence and the Genome. Chicago, Illinois, University of Chicago Press, 1990.
35. Dimri GP, Lee X, Basile G, et al. A novel biomarker identifies senescent human cells in culture and aging skin in vivo. Proc Natl Acad Sci USA 1995, 92, 9363-9367.
36. Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatrics Soc 1997, 45, 1-6.
37. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995, 5, 249-255.
38. Hara E, Tsuri H, Shinozaki S, Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of lifespan in human diploid fibroblasts, TIG-1. Biochem Biophys Res Comm 1991, 179, 528-534.
39. Shay JW, Wright WE, Brasiskyte D, Vanderhaegen BA. E6 of human papillomavirus type-16 can overcome the M1 stage immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 1993, 8, 1407-1413.
40. Wazer DE, Liu XL, Chu Q, Gao Q, Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci USA 1995, 92, 3687-3691.
41. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992, 225, 951-960.
42. Tommerup H, Dousmanis A, De Lange T. Unusual chromatin in human telomeres. Mol Cell Biol 1994, 14, 5777-5785.
43. Blackburn EH. Structure and function of telomeres. Nature 1991, 350, 569-573.
44. Blackburn EH. Telomerases. Ann Rev Biochem 1992, 61, 113-129.
45. Allshire RC, Dempster M, Hastie ND. Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res 1989, 17, 4611-4627.
46. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990, 345, 458-460.
47. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Nature 1990, 346, 866-868.
48. Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991, 256, 45-48.
49. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89, 10114-10118.
50. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995, 219, 130-136.
51. Wright WE, Brasiskyte D, Piatyszek M, Shay JW. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J 1996, 15, 1734-1741.
52. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 226, 2011-2015.
53. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995, 85, 2315-2320.
54. Hiyama K, Hirai Y, Kyoisumi S, et al. Telomerase activity in human peripheral blood and bone marrow cells. J Immunol 1995, 155, 3711-3715.
55. Landsdorp PM. Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci 1995, 108, 1-6.
56. Prowse KR, Greider CW. Development and tissue specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995, 92, 4818-4822.
57. Broccoli D, Young JW, DeLange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 93, 9083-9086.
58. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genetics 1996, 18, 173-179.
59. Vaziri H, Schachter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993, 52, 661-667.
60. Buchkovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Cell Biol 1996, 7, 1443-1454.
61. Effros RB. Insights on immunological aging derived from the T lymphocyte cellular senescence model. Exp Gerontol 1996, 31, 21-27.
62. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996, 183, 2471-2479.
63. Harlebachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci 1996, 93, 6476-6481.
64. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14, 4240-4248.
65. Strahl C, Blackburn EH. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 1996, 16, 53-65.
66. Wright WE, Shay JW. Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism? Trends Cell Biol 1995, 5, 293-297.
67. Sandell LL, Zakian VA. Loss of a yeast telomere: arrest, recovery and chromosome loss. Cell 1993, 75, 729-739.
68. Afshari CA, Vojta PJ, Annab LA, Futreal PA, Willard TB, Barrett JC. Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp Cell Res 1993, 209, 231-237.
69. Oshima J, Campisi J, Tannock CA, Martin GM. Regulation of c-fos in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors. J Cell Physiol 1995, 162, 277-283.
70. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989, 9, 3088-3092.
71. Radna RL, Caton Y, Jha KK, et al. Growth of immortal simian virus 40 ts-A transformed human fibroblasts is temperature dependent. Mol Cell Biol 1989, 9, 3093-3096.
72. Marcand S, Buck SW, Moretti P, Gilson E, Shore D. Silencing of genes at nontelomeric sites in yeast is controlled by sequestration of silencing factors at telomeres by Rap1 protein. Genes Dev 1996, 10, 1297-1309.
73. Shay JW, Werbin H, Wright WE. You haven't heard the end of it: telomere loss may link human aging with cancer. Can J Aging 1995, 14, 511-524.
74. Wright WE, Shay JW. Telomere positional effects and the regulation of cellular senescence. Trends Genet 1992, 8, 193-197.
75. Laurenson P, Rine J. Silencers, silencing and heritable transcriptional states. Microbiol Rev 1992, 56, 543-560.
76. Shore D. Telomere position effect and transcriptional silencing in the yeast Saccharomyces cerevisiae. In Blackburn EH, Greider CW, eds. Telomeres. Cold Spring Harbor Press, 1995, 247-263.
77. Ogryzko VV, Harai TH, Russanova VR, Barbie DA, Howard BH. Human fibroblast commitment to a senescence-like state in responses to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol 1996, 16, 5210-5218.
78. Kim S, Villeponteau B, Jazwinski SM. Effect of replicative age on transcriptional silencing near telomeres in Saccharomyces cerevisiae. Biochem Biophys Res Comm 1996, 219, 370-376.
79. Smeal T, Claus J, Kennedy B, Cole F, Guarente L. Loss of transcriptional silencing causes sterility in old mother cells of S. cerevisiae. Cell 1996, 84, 633-642.